Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. OLPX
OLPX logo

OLPX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
2.020
Open
2.000
VWAP
2.01
Vol
10.63M
Mkt Cap
1.36B
Low
2.000
Amount
21.39M
EV/EBITDA(TTM)
20.92
Total Shares
671.71M
EV
1.39B
EV/OCF(TTM)
23.70
P/S(TTM)
3.19
Olaplex Holdings, Inc. is a foundational health and beauty company. Its Complete Bond Technology works by protecting, strengthening and relinking all three bonds during and after hair services. Its product portfolio includes 23 products that support the hair health needs of its professional hairstylist and consumer communities. It developed its patent-protected bond-building technology, Bis-amino, which works on the molecular level to repair the hair’s disulfide bonds. Leveraging its Bis-amino technology, its two-part salon and at home bond-building treatments are complete bond builders that can repair all three main chemical bonds deep inside the hair: hydrogen, ionic and disulfide bonds. Its OLAPLEX Bond Shaping Technology is a proprietary peptide that penetrates deep into the hair to strengthen, rebuild, and reform curl-shaping disulfide bonds. Its products are sold globally through an omnichannel model serving the professional, specialty retail, and direct-to-consumer channels.
Show More

Events Timeline

(ET)
2026-03-27
08:50:00
Rackspace Technology Borrow Rate Increases to 14.06%
select
2026-03-26 (ET)
2026-03-26
16:30:00
Major Averages Decline Amid Rising Oil Prices
select
2026-03-26
12:10:00
Major Averages Decline Amid Rising Oil Prices
select
2026-03-26
08:40:00
Northland Downgrades Olaplex to Market Perform After $2.06 Acquisition by Henkel
select
2026-03-26
05:10:00
Olaplex to be Acquired by Henkel for $2.06 per Share
select
2026-03-05 (ET)
2026-03-05
07:00:00
OLAPLEX Q4 Revenue $105.11M Beats Expectations
select
2026-03-05
07:00:00
Sees FY26 Adjusted Gross Profit Margin 71%-72%
select

News

NASDAQ.COM
8.5
03-27NASDAQ.COM
Biotech Landscape Update: Regulatory Approvals and Mergers
  • Anavex Drug Withdrawal: Anavex Life Sciences Corp. (AVXL) withdrew its EU marketing application for Alzheimer's drug Blarcamesine after the EMA's CHMP indicated it could not issue a positive opinion, marking a significant setback for the company's lead candidate despite continued support from patient groups.
  • Quoin FDA Alignment: Quoin Pharmaceuticals Ltd. (QNRX) received positive feedback from the FDA confirming that a single Phase 3 trial may suffice for U.S. approval of QRX003 for Netherton Syndrome, with plans to initiate Phase 3 in 2026 and potentially file an NDA in 2027.
  • Corcept Drug Approval: Corcept Therapeutics Inc. (CORT) secured FDA approval for Lifyorli combined with nab-paclitaxel to treat platinum-resistant ovarian cancer, based on Phase 3 ROSELLA trial results involving 381 patients, marking the first FDA-approved selective glucocorticoid receptor antagonist.
  • Merck Acquires Terns: Merck (MRK) announced a definitive agreement to acquire Terns Pharmaceuticals for $53.00 per share, totaling approximately $6.7 billion, which is expected to enhance Merck's presence in hematology, with the transaction anticipated to close in Q2 2026.
NASDAQ.COM
6.0
03-27NASDAQ.COM
Olaplex Stock Surpasses Analyst Target Price
  • Stock Performance: Olaplex Holdings Inc's shares have surpassed the average analyst 12-month target price of $1.84, currently trading at $2.01, indicating market optimism regarding the company's future prospects.
  • Analyst Reactions: When a stock reaches an analyst's target price, they may either downgrade on valuation or raise the target, reflecting the market's focus on fundamental changes at Olaplex, which could influence investor decisions.
  • Target Price Distribution: Among the 8 analysts covered by Zacks, target prices range from $1.40 to $2.50, with a standard deviation of $0.367, highlighting differing views on Olaplex's future performance, necessitating careful investor assessment.
  • Investor Signal: The stock's rise above the target price provides a good signal for investors to reassess the company, prompting them to consider whether the current valuation is justified or if it might be time to take profits.
Fool
8.5
03-26Fool
Olaplex Acquired by Henkel for $2.06 per Share
  • Acquisition Deal: German consumer goods giant Henkel has agreed to acquire Olaplex for $2.06 per share in cash, totaling $1.4 billion, marking the end of Olaplex's disappointing run as a public company.
  • Stock Surge: Following the announcement, Olaplex's stock surged by 51.13% to close at $2.01, with trading volume reaching 104.6 million shares, approximately 2,904% above its three-month average, indicating strong market reaction to the acquisition.
  • Market Performance: Since its IPO in 2021, Olaplex's stock has plummeted by 92%, and this acquisition provides much-needed liquidity, potentially offering investors a timely exit opportunity.
  • Industry Consolidation: Olaplex's niche products may find better synergy within Henkel's brand portfolio, and the acquisition could help Henkel expand its influence in the personal care market while providing Olaplex with stronger market support.
stocktwits
8.5
03-26stocktwits
Olaplex Holdings Attracts Wall Street Interest Following Henkel's $1.4 Billion Acquisition Agreement
  • Olaplex Acquisition Announcement: Olaplex announced its acquisition by Henkel for $2.06 per share, valued at approximately $1.4 billion, which led to a downgrade in its stock ratings by several analysts.

  • Stock Price Adjustments: Following the acquisition announcement, Evercore ISI lowered its price target for Olaplex from $2.50 to $2.06 while maintaining an 'In Line' rating on the stock.

  • Market Reaction: Despite the downgrades, Olaplex's stock surged over 50% after the acquisition news, indicating a shift in market sentiment from bearish to bullish.

  • Future Prospects: The acquisition is expected to enhance Olaplex's market presence and innovation opportunities, with the transaction anticipated to close in the second half of 2026, pending regulatory approvals.

PRnewswire
8.5
03-26PRnewswire
Investigation Launched into Olaplex's Transaction with Henkel
  • Shareholder Rights Investigation: Ademi LLP is investigating Olaplex (NASDAQ:OLPX) for potential breaches of fiduciary duty and other legal violations related to its transaction with Henkel, aiming to protect the rights of all shareholders.
  • Transaction Details Revealed: In this deal, Olaplex shareholders will receive $2.06 per share in a cash transaction valued at approximately $1.4 billion, while insiders are set to gain substantial benefits, raising concerns about potential conflicts of interest.
  • Competition Limitation Clauses: The transaction agreement includes unreasonable terms that restrict Olaplex from accepting competing bids, imposing significant penalties for doing so, which could undermine the best interests of shareholders.
  • Board Accountability Review: We are examining the conduct of Olaplex's board of directors to assess whether they are fulfilling their fiduciary duties to all shareholders, ensuring transparency and compliance to safeguard shareholder rights.
CNBC
8.5
03-26CNBC
Henkel Acquires Olaplex for $1.4 Billion
  • Acquisition Overview: German consumer brand Henkel has announced its agreement to acquire the prestige haircare brand Olaplex for $1.4 billion, with an offer price of $2.06 per share, unanimously approved by Olaplex's board, marking a significant milestone in Henkel's business strategy.
  • Strategic Alignment: Henkel CEO Carsten Knobel stated that the acquisition aligns perfectly with the company's strategy to expand its portfolio through compelling M&A activities, thereby enhancing its presence in the premium hair care market.
  • Stock Price Reaction: Following the announcement, Olaplex's shares surged by 50%, rising from approximately $1.30 on Wednesday to around $2.06, reflecting a positive market response despite the company's previous struggles with lawsuits and competition.
  • Future Growth Potential: Olaplex CEO Amanda Baldwin emphasized that this acquisition provides a platform for the company to explore new opportunities for innovation and growth, showcasing the momentum achieved in its transformation and the significant prospects for long-term growth.
Wall Street analysts forecast OLPX stock price to rise
7 Analyst Rating
Wall Street analysts forecast OLPX stock price to rise
2 Buy
4 Hold
1 Sell
Hold
Current: 0.000
sliders
Low
1.25
Averages
1.98
High
4.00
Current: 0.000
sliders
Low
1.25
Averages
1.98
High
4.00
Telsey Advisory
Market Perform
maintain
$2
AI Analysis
2026-03-27
New
Reason
Telsey Advisory
Price Target
$2
AI Analysis
2026-03-27
New
maintain
Market Perform
Reason
Telsey Advisory raised the firm's price target on Olaplex (OLPX) to $2.06 from $2 and keeps a Market Perform rating on the shares. The transaction between Henkel (HENKY) and Olaplex does not come as a surprise, with the firm believing Henkel is a "natural acquisition fit" given its branded haircare product portfolio, the analyst tells investors.
Canaccord
Buy
to
Hold
downgrade
$2
2026-03-26
New
Reason
Canaccord
Price Target
$2
2026-03-26
New
downgrade
Buy
to
Hold
Reason
Canaccord downgraded Olaplex to Hold from Buy with an unchanged price target of $2 after the company agreed to be acquired by Henkel for $2.06 per share in cash.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for OLPX
Unlock Now

Valuation Metrics

The current forward P/E ratio for Olaplex Holdings Inc (OLPX.O) is 14.42, compared to its 5-year average forward P/E of 22.44. For a more detailed relative valuation and DCF analysis to assess Olaplex Holdings Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
22.44
Current PE
14.42
Overvalued PE
36.20
Undervalued PE
8.67

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
15.23
Current EV/EBITDA
10.46
Overvalued EV/EBITDA
24.42
Undervalued EV/EBITDA
6.03

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
6.48
Current PS
2.09
Overvalued PS
12.79
Undervalued PS
0.18

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

give me penny stocks
Intellectia · 42 candidates
Market Cap: 50.00M - 1000.00MRegion: USPrice: $0.50 - $5.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEMonth Price Change Pct: $10.00 - $150.00Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
WTI logo
WTI
W&T Offshore Inc
446.33M
SABR logo
SABR
Sabre Corp
596.71M
SIDU logo
SIDU
Sidus Space Inc
188.92M
AIRS logo
AIRS
AirSculpt Technologies Inc
190.43M
NRGV logo
NRGV
Energy Vault Holdings Inc
636.55M
OLPX logo
OLPX
Olaplex Holdings Inc
890.31M
stocks under $5 for likely day trade today
Intellectia · 70 candidates
Price: $0.50 - $5.00Price Change Pct: $3.00 - $20.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
CIG logo
CIG
Energy of Minas Gerais Co
6.52B
TUYA logo
TUYA
Tuya Inc
1.42B
ODV logo
ODV
Osisko Development Corp
1.15B
GERN logo
GERN
Geron Corp
1.13B
SANA logo
SANA
Sana Biotechnology Inc
1.08B
OLPX logo
OLPX
Olaplex Holdings Inc
1.07B
less than 3 usd
Intellectia · 1118 candidates
Price: <= $3.00
Ticker
Name
Market Cap$
top bottom
ABEV logo
ABEV
Ambev SA
41.38B
WIT logo
WIT
Wipro Ltd
27.24B
CIG.C logo
CIG.C
Companhia Energetica De Minas Gerais-CEMIG
7.70B
CIG logo
CIG
Energy of Minas Gerais Co
5.98B
FUBO logo
FUBO
FuboTV Inc
3.33B
PLUG logo
PLUG
Plug Power Inc
3.09B
best $5 stocks to buy now
Intellectia · 71 candidates
Market Cap: >= 500.00MPrice: <= $5.00Weekly Average Turnover: >= 1,000,000Month Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
UP logo
UP
Wheels Up Experience Inc
624.57M
ASST logo
ASST
Strive Inc
1.11B
KOS logo
KOS
Kosmos Energy Ltd
617.04M
OPK logo
OPK
OPKO Health Inc
1.06B
LXRX logo
LXRX
Lexicon Pharmaceuticals Inc
566.90M
OLPX logo
OLPX
Olaplex Holdings Inc
1.06B
focus on growth and value
Intellectia · 28 candidates
Market Cap: >= 500.00MPrice: <= $5.00Revenue 5yr Cagr: >= 15Pe Ttm: <= 15
Ticker
Name
Market Cap$
top bottom
NIO logo
NIO
NIO Inc
11.55B
CSAN logo
CSAN
Cosan SA
4.02B
FUBO logo
FUBO
FuboTV Inc
3.33B
PLUG logo
PLUG
Plug Power Inc
3.09B
RXRX logo
RXRX
Recursion Pharmaceuticals Inc
2.40B
CLVT logo
CLVT
Clarivate PLC
1.86B
I want to buy penny stock
Intellectia · 182 candidates
Market Cap: <= 2.00BPrice: <= $5.00Beta: HighRiskWeekly Average Turnover: >= 1,000,000Is Optionable: True
Ticker
Name
Market Cap$
top bottom
MQ logo
MQ
Marqeta Inc
1.94B
CLVT logo
CLVT
Clarivate PLC
1.86B
NWL logo
NWL
Newell Brands Inc
1.79B
TV logo
TV
Grupo Televisa SAB
1.74B
BITF logo
BITF
Bitfarms Ltd
1.61B
PGEN logo
PGEN
Precigen Inc
1.58B
shortterm returns between 1 and 2 $
Intellectia · 449 candidates
Price: $1.00 - $2.00
Ticker
Name
Market Cap$
top bottom
SID logo
SID
Companhia Siderurgica Nacional SA
2.36B
ABTC logo
ABTC
American Bitcoin Corp
1.46B
OPK logo
OPK
OPKO Health Inc
1.06B
OLPX logo
OLPX
Olaplex Holdings Inc
1.06B
LOT logo
LOT
Lotus Technology Inc
943.46M
AHG logo
AHG
Akso Health Group
866.42M

Whales Holding OLPX

A
Advent International, L.P.
Holding
OLPX
-17.95%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Olaplex Holdings Inc (OLPX) stock price today?

The current price of OLPX is 2.02 USD — it has increased 0.5

What is Olaplex Holdings Inc (OLPX)'s business?

Olaplex Holdings, Inc. is a foundational health and beauty company. Its Complete Bond Technology works by protecting, strengthening and relinking all three bonds during and after hair services. Its product portfolio includes 23 products that support the hair health needs of its professional hairstylist and consumer communities. It developed its patent-protected bond-building technology, Bis-amino, which works on the molecular level to repair the hair’s disulfide bonds. Leveraging its Bis-amino technology, its two-part salon and at home bond-building treatments are complete bond builders that can repair all three main chemical bonds deep inside the hair: hydrogen, ionic and disulfide bonds. Its OLAPLEX Bond Shaping Technology is a proprietary peptide that penetrates deep into the hair to strengthen, rebuild, and reform curl-shaping disulfide bonds. Its products are sold globally through an omnichannel model serving the professional, specialty retail, and direct-to-consumer channels.

What is the price predicton of OLPX Stock?

Wall Street analysts forecast OLPX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OLPX is1.98 USD with a low forecast of 1.25 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Olaplex Holdings Inc (OLPX)'s revenue for the last quarter?

Olaplex Holdings Inc revenue for the last quarter amounts to 105.12M USD, increased 4.35

What is Olaplex Holdings Inc (OLPX)'s earnings per share (EPS) for the last quarter?

Olaplex Holdings Inc. EPS for the last quarter amounts to -0.02 USD, increased 100.00

How many employees does Olaplex Holdings Inc (OLPX). have?

Olaplex Holdings Inc (OLPX) has 278 emplpoyees as of March 30 2026.

What is Olaplex Holdings Inc (OLPX) market cap?

Today OLPX has the market capitalization of 1.36B USD.